FPHAX : Fidelity® Select Pharmaceuticals Portfolio

FPHAX is a Sector Equity Market Healthcare with MODERATE fees.

FPHAX

Fidelity® Select Pharmaceuticals Portfolio

FI Score

38 /100

Expense Ratio Rating

6 /10

Expense Rating

2 /10

Market Score

5 /10

Category Score

0 /10

Market Size

5 /10

Similar Funds

We found 107 Sector Equity Healthcare funds. Here they are ordered by FI Score.

Compare FPHAX vs LNGR

44% FI Score
  • lngr
  • ETF
  • Sector Equity
  • Healthcare

Global X Longevity Thematic ETF

Expenses: 0.50% (Better than 1% of similar funds)

This is a bad choice for a Healthcare Sector Equity fund. See why »

Compare FPHAX vs SHSAX

43% FI Score
  • shsax
  • Mutual Fund
  • Sector Equity
  • Healthcare

BlackRock Health Sciences Opportunities Portfolio Investor A Shares

Expenses: 1.12% (Better than 0% of similar funds)

This is a bad choice for a Healthcare Sector Equity fund. See why »

Compare FPHAX vs GNOM

43% FI Score
  • gnom
  • ETF
  • Sector Equity
  • Healthcare

Global X Genomics & Biotechnology ETF

Expenses: 0.68% (Better than 1% of similar funds)

This is a bad choice for a Healthcare Sector Equity fund. See why »

Compare FPHAX vs SHISX

43% FI Score
  • shisx
  • Mutual Fund
  • Sector Equity
  • Healthcare

BlackRock Health Sciences Opportunities Portfolio Service Shares

Expenses: 1.15% (Better than 0% of similar funds)

This is a bad choice for a Healthcare Sector Equity fund. See why »

Compare FPHAX vs FTXH

42% FI Score
  • ftxh
  • ETF
  • Sector Equity
  • Healthcare

First Trust Nasdaq Pharmaceuticals ETF

Expenses: 0.60% (Better than 1% of similar funds)

This is a bad choice for a Healthcare Sector Equity fund. See why »

Compare FPHAX vs FSHCX

42% FI Score
  • fshcx
  • Mutual Fund
  • Sector Equity
  • Healthcare

Fidelity® Select Health Care Services Portfolio

Expenses: 0.75% (Better than 1% of similar funds)

This is a bad choice for a Healthcare Sector Equity fund. See why »

Compare FPHAX vs CNCR

39% FI Score
  • cncr
  • ETF
  • Sector Equity
  • Healthcare

Loncar Cancer Immunotherapy ETF

Expenses: 0.79% (Better than 1% of similar funds)

This is a bad choice for a Healthcare Sector Equity fund. See why »

Compare FPHAX vs BBC

39% FI Score
  • bbc
  • ETF
  • Sector Equity
  • Healthcare

Virtus LifeSci Biotech Clinical Trials ETF

Expenses: 0.79% (Better than 1% of similar funds)

This is a bad choice for a Healthcare Sector Equity fund. See why »

Compare FPHAX vs BBP

38% FI Score
  • bbp
  • ETF
  • Sector Equity
  • Healthcare

Virtus LifeSci Biotech Products ETF

Expenses: 0.79% (Better than 1% of similar funds)

This is a bad choice for a Healthcare Sector Equity fund. See why »

Compare FPHAX vs SHSCX

37% FI Score
  • shscx
  • Mutual Fund
  • Sector Equity
  • Healthcare

BlackRock Health Sciences Opportunities Portfolio Investor C Shares

Expenses: 1.85% (Better than 0% of similar funds)

This is a bad choice for a Healthcare Sector Equity fund. See why »

Minafi - The intersection of FI, minimalism & mindfulness.

Don't miss out on new posts, courses, interactive articles and more!

Join & Get Your First Course Free

© 2024   Adam Fortuna

Site Map
Triangle Graduation Cap Angle Down Book regular Phone laptop regular fire regular fire regular search regular Acorn duotone Seedling duotone thumbs down duo thumbs up duo